- Filed
- Sep 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Jul 31, 2025 | 38.28M sh |
| Shares Diluted | Q3 2025 · Jul 31, 2024 | 36.97M sh |
| Shares Outstanding | Q3 2025 · Jul 31, 2025 | 38.5M sh |
| Capex | Q3 2025 · Jul 31, 2025 | $10.67K |
| Capex | Q3 2025 · Jul 31, 2024 | $9.56K |
| Operating Cash Flow | Q3 2025 · Jul 31, 2025 | $320.84K |
| Operating Cash Flow | Q3 2025 · Jul 31, 2024 | −$41.51K |
| Cash And Equivalents | Q3 2025 · Jul 31, 2025 | $532.43K |
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $185.68K |
| Stockholders Equity | Q3 2025 · Jul 31, 2025 | $1.87M |
| Stockholders Equity | Q3 2025 · Apr 30, 2025 | $1.81M |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | $1.56M |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $1.44M |
| Stockholders Equity restated | Q3 2025 · Jul 31, 2024 | −$1.25M |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | $1.3M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $1.27M |
| Stockholders Equity restated | Q3 2025 · Oct 31, 2023 | $1.11M |
| Current Liabilities | Q3 2025 · Jul 31, 2025 | $213.86K |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $166.46K |
| Total Liabilities | Q3 2025 · Jul 31, 2025 | $236.76K |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $249.95K |
| Current Assets | Q3 2025 · Jul 31, 2025 | $1.31M |
| Current Assets | Q3 2025 · Oct 31, 2024 | $1.01M |
| Total Assets | Q3 2025 · Jul 31, 2025 | $2.1M |
| Total Assets | Q3 2025 · Oct 31, 2024 | $1.69M |
| Eps Diluted | Q3 2025 · Jul 31, 2025 | $0.01 |
| Eps Diluted | Q3 2025 · Jul 31, 2025 | $0.00 |
| Eps Diluted restated | Q3 2025 · Jul 31, 2024 | $0.00 |
| Eps Diluted restated | Q3 2025 · Jul 31, 2024 | −$0.00 |
| Eps Basic | Q3 2025 · Jul 31, 2025 | $0.01 |
| Eps Basic | Q3 2025 · Jul 31, 2025 | $0.00 |
| Eps Basic restated | Q3 2025 · Jul 31, 2024 | $0.00 |
| Eps Basic restated | Q3 2025 · Jul 31, 2024 | −$0.00 |
| Sga Expense | Q3 2025 · Jul 31, 2025 | $192.83K |
| Sga Expense | Q3 2025 · Jul 31, 2025 | $664.73K |
| Sga Expense | Q3 2025 · Jul 31, 2024 | $142.22K |
| Sga Expense | Q3 2025 · Jul 31, 2024 | $348.95K |
| Net Income | Q3 2025 · Jul 31, 2025 | $62.44K |
| Net Income | Q3 2025 · Apr 30, 2025 | $204.19K |
| Net Income | Q3 2025 · Jan 31, 2025 | $36.2K |
| Net Income | Q3 2025 · Jul 31, 2024 | −$59.08K |
| Net Income | Q3 2025 · Apr 30, 2024 | $22.23K |
| Net Income | Q3 2025 · Jan 31, 2024 | −$63.39K |
| Operating Income | Q3 2025 · Jul 31, 2025 | $63.7K |
| Operating Income | Q3 2025 · Jul 31, 2025 | $305.19K |
| Operating Income | Q3 2025 · Jul 31, 2024 | −$53.92K |
| Operating Income | Q3 2025 · Jul 31, 2024 | −$80.81K |
| Revenue | Q3 2025 · Jul 31, 2025 | $612.64K |
| Revenue | Q3 2025 · Jul 31, 2025 | $1.95M |
| Revenue | Q3 2025 · Jul 31, 2024 | $278.28K |
| Revenue | Q3 2025 · Jul 31, 2024 | $644.5K |